Actively Recruiting
Phase 3
Age: 3Years - 12Years
All Genders
NCT04766177
Role of Bumetanide in Treatment of Autism
Led by Sherief Abd-Elsalam · Updated on 2021-02-23
80
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Role of bumetanide in Autism
CONDITIONS
Official Title
Role of Bumetanide in Treatment of Autism
Who Can Participate
Age: 3Years - 12Years
All Genders
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Autism Spectrum Disorder by CARS rating Scale score of 30 or higher
- Age between 3 and 12 years
You will not qualify if you...
- Autism Spectrum Disorder with neurological history including epilepsy or febrile seizures
- Presence of liver or kidney dysfunction
- Electrocardiogram abnormalities
- Syndromic conditions such as Rett syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Loading map...
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here